1-isopropyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxylic acid hydrochloride dihydrate, 95.0%, 1g

4-Aminopyridin-2-ol, 97.0%, 25g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)butanoic acid, 97%, 1g

2-(3,4,5-trimethyl-1H-pyrazol-1-yl)ethanamine, 95.0%, 1g

3-(tert-butoxycarbonyl)-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid, 95.0%, 5g

2-Cyanobenzoic acid, 95.0%, 100g

1,1,2,3,3,3-Hexafluoropropyl Methyl Ether>98.0%(GC)25g

Fruquintinib, 98%, 1g

1-((2R,3R,4R,5R)-3-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98%, 250mg

(4-(N-Cyclopropylsulfamoyl)phenyl)boronic acid, 95.0%, 250mg

2-(2-Imino-1,3-thiazolidin-3-yl)-1-phenylethan-1-ol hydrochloride, 95+%, 500mg

trans-1,2-Cyclohexanediol>99.0%(GC)5g

3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine, 95.0%, 250mg